普瑞巴林撤药后出现的谵妄
Delirium After Pregabalin Withdrawal.
作者信息
Çalışkan Ali Metehan, İnanlı İkbal, Çalışkan Sıla, Eren İbrahim
机构信息
Department of Psychiatry, University of Health Sciences Konya Training and Research Hospital, Konya, Turkey.
Department of Psychiatry, Bolu Abant İzzet Baysal University Faculty of Medicine, Bolu, Turkey.
出版信息
Alpha Psychiatry. 2021 Mar 18;22(2):118-119. doi: 10.5455/apd.117770. eCollection 2021 Mar.
Abstract
Pregabalin is a γ-amino butyric acid analogue drug that is used in fibromyalgia, neuropathic pain associated with diabetic peripheral neuropathy, spinal cord injury, and postherpetic neuralgia. Symptoms reported in association with pregabalin withdrawal include insomnia, gastrointestinal distress, tachycardia, and headache. This case report describes a 68-year-old patient who developed delirium after experiencing pregabalin withdrawal. Clinicians should be aware of the possibility of pregabalin withdrawal delirium.
摘要
普瑞巴林是一种γ-氨基丁酸类似物药物，用于治疗纤维肌痛、与糖尿病性周围神经病变相关的神经性疼痛、脊髓损伤和带状疱疹后神经痛。与普瑞巴林戒断相关的报告症状包括失眠、胃肠道不适、心动过速和头痛。本病例报告描述了一名68岁患者在经历普瑞巴林戒断后出现谵妄。临床医生应意识到普瑞巴林戒断谵妄的可能性。
相似文献
1
Delirium After Pregabalin Withdrawal.
Alpha Psychiatry. 2021 Mar 18;22(2):118-119. doi: 10.5455/apd.117770. eCollection 2021 Mar.
2
Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.
Clin Ther. 2007 Jan;29(1):26-48. doi: 10.1016/j.clinthera.2007.01.013.
3
The effect of pregabalin on pain-related sleep interference in diabetic peripheral neuropathy or postherpetic neuralgia: a review of nine clinical trials.
Curr Med Res Opin. 2010 Oct;26(10):2411-9. doi: 10.1185/03007995.2010.516142.
4
Pregabalin for acute and chronic pain in adults.
Cochrane Database Syst Rev. 2009 Jul 8(3):CD007076. doi: 10.1002/14651858.CD007076.pub2.
5
Acute withdrawal in the postoperative setting in a patient taking standard therapeutic doses of pregabalin.
J Surg Case Rep. 2023 Jun 27;2023(6):rjad375. doi: 10.1093/jscr/rjad375. eCollection 2023 Jun.
6
A Case Report on Pregabalin-Induced Eosinophilia.
Consult Pharm. 2018 Jun 1;33(6):317-320. doi: 10.4140/TCP.n.2018.317.
7
Dose-response of pregabalin for diabetic peripheral neuropathy, postherpetic neuralgia, and fibromyalgia.
Postgrad Med. 2017 Nov;129(8):921-933. doi: 10.1080/00325481.2017.1384691. Epub 2017 Oct 16.
8
A Clinical Overview of Off-label Use of Gabapentinoid Drugs.
JAMA Intern Med. 2019 May 1;179(5):695-701. doi: 10.1001/jamainternmed.2019.0086.
9
Pregabalin in acute and chronic pain.
J Anaesthesiol Clin Pharmacol. 2011 Jul;27(3):307-14. doi: 10.4103/0970-9185.83672.
10
Population pharmacokinetics of pregabalin in healthy subjects and patients with post-herpetic neuralgia or diabetic peripheral neuropathy.
Br J Clin Pharmacol. 2011 Jul;72(1):63-76. doi: 10.1111/j.1365-2125.2011.03932.x.
引用本文的文献
1
Rebound effect, discontinuation, and withdrawal syndromes associated with drugs used in psychiatric and neurological disorders.
Pharmacol Rep. 2025 Apr;77(2):303-314. doi: 10.1007/s43440-024-00689-z. Epub 2024 Dec 23.
2
The Effect of Oral Gabapentin and Pregabalin as a Prodrug in Pain Control after Orthopedic Surgery on the Upper Limb: A Double-Blind Parallel Randomized Clinical Trial Study.
Anesthesiol Res Pract. 2024 May 6;2024:7193599. doi: 10.1155/2024/7193599. eCollection 2024.
3
Role of Palliative Care in the Supportive Management of AL Amyloidosis-A Review.
J Clin Med. 2024 Mar 29;13(7):1991. doi: 10.3390/jcm13071991.
4
Delirium following pregabalin discontinuation in an individual with no psychiatric or substance use history.
BMJ Case Rep. 2023 Nov 17;16(11):e258104. doi: 10.1136/bcr-2023-258104.
5
Acute withdrawal in the postoperative setting in a patient taking standard therapeutic doses of pregabalin.
J Surg Case Rep. 2023 Jun 27;2023(6):rjad375. doi: 10.1093/jscr/rjad375. eCollection 2023 Jun.
本文引用的文献
1
Development of a Novel Controlled-Release Tablet of Pregabalin: Formulation Variation and Pharmacokinetics in Dogs and Humans.
Drug Des Devel Ther. 2020 Jan 30;14:445-456. doi: 10.2147/DDDT.S222505. eCollection 2020.
2
A systematic review and meta-analysis of pregabalin preclinical studies.
Pain. 2020 Apr;161(4):684-693. doi: 10.1097/j.pain.0000000000001749.
3
A Clinical Overview of Off-label Use of Gabapentinoid Drugs.
JAMA Intern Med. 2019 May 1;179(5):695-701. doi: 10.1001/jamainternmed.2019.0086.
4
[Pregabalin can cause addiction and withdrawal symptoms].
Ugeskr Laeger. 2015 Jan 26;177(2A):38-9.
5
Delirium after gabapentin withdrawal. Case report.
Can J Neurol Sci. 2013 Jan;40(1):126-7. doi: 10.1017/s0317167100017418.
6
Delirium, psychosis, and visual hallucinations induced by pregabalin.
Arq Neuropsiquiatr. 2012 Dec;70(12):960-1. doi: 10.1590/s0004-282x2012001200012.
7
Delirium secondary to pregabalin.
Gen Hosp Psychiatry. 2012 Jul-Aug;34(4):436.e1-2. doi: 10.1016/j.genhosppsych.2011.11.004. Epub 2011 Dec 15.
8
A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin.
Clin Pharmacokinet. 2010 Oct;49(10):661-9. doi: 10.2165/11536200-000000000-00000.
9
Pregabalin-withdrawal encephalopathy and splenial edema: a link to high-altitude illness?
Ann Neurol. 2005 Aug;58(2):309-12. doi: 10.1002/ana.20583.
Zotero 插件